Skip to main content
. Author manuscript; available in PMC: 2006 Mar 8.
Published in final edited form as: J Immunol. 2005 May 15;174(10):5987–5993. doi: 10.4049/jimmunol.174.10.5987

FIGURE 3.

FIGURE 3

TGF-β1 inhibits FcεRI surface expression on mouse peritoneal mast cells and cultured human mast cells. A, Mouse peritoneal lavage cells were cultured in IL-3 and SCF with or without TGF-β1 for 3 days. Data shown are the average and SD of four separate populations, showing the mean fluorescence intensity of FcεRI staining on Kit-positive cells (mast cells) in the presence or the absence of TGF-β1. B, Human mast cells were cultured in SCF with or without TGF-β1 (15 ng/ml) for 3 days. FcεRI surface expression was determined by flow cytometry using anti-FcεRIα or a control Ab. Results are representative of two different mast cell cultures.

HHS Vulnerability Disclosure